Back to search
FDAFDA · Food and drugs·Recall number D-0581-2024

Eszopiclone Tablets, USP 1mg CIV, 30-count bottle, Rx only, Mfd. By: Dr. Reddy's Laboratories Limited, Bachupally - 500 090 INDIA, NDC 55111-629-30

Published July 10, 2024 · Recall initiated: June 4, 2024

Summary

FDA records drug Class III recall D-0581-2024, published July 10, 2024 and initiated June 4, 2024. Recalling firm: Dr. Reddy's Laboratories, Inc.; Status: Ongoing; Reported quantity: 13,752 bottles; Lot: Lot#: C2302598, Exp 2/29/2025. Class III means the product is not likely to cause adverse health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Impurities/Degradation Specifications: Related Substances

What to do

Voluntary: Firm initiated

Get an email if ESZOPICLONE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
ESZOPICLONE
Manufacturer
Dr. Reddy's Laboratories, Inc.
Distributor
OH, MS
UPC
0355111617013
Lot
Lot#: C2302598, Exp 2/29/2025
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Eszopiclone Tablets, USP 1mg CIV, 30-count bottle, Rx only, Mfd. By: Dr. Reddy's Laboratories Limited, Bachupally - 500 090 INDIA, NDC 55111-629-30 recalled?

Yes. FDA published recall D-0581-2024 on July 10, 2024. Reported hazard: Failed Impurities/Degradation Specifications: Related Substances

What should I do if I have this product?

Voluntary: Firm initiated

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: ESZOPICLONE. UPC: 0355111617013.